Tenet Healthcare (NYSE: THC) COO gains 3,800 shares from RSU vesting

Rhea-AI Filing Summary

Tenet Healthcare executive Lisa Y. Foo reported the vesting and conversion of restricted stock units into common shares. On February 24, 2026, 3,800 of her 2025 Restricted Stock Units converted into 3,800 shares of Tenet Healthcare common stock at no exercise price, reflecting an exercise or conversion of a derivative security.

These restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in equal one-third installments on each of the first three anniversaries of the grant date. The first one-third installment vested on February 24, 2026. Following this transaction, she directly holds 53,017 shares of common stock and 7,602 restricted stock units.

Insider Trade Summary

3,800 shares exercised/converted

Mixed 2 txns

Insider Foo Lisa Y

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	2025 Restricted Stock Units	3,800	$0.00	--
Exercise	Common Stock	3,800	$0.00	--

Holdings After Transaction: 2025 Restricted Stock Units — 7,602 shares (Direct); Common Stock — 53,017 shares (Direct)

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foo Lisa Y

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		3,800	A	(1)	53,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2025 Restricted Stock Units	(2)	02/24/2026		M			3,800	(2)	(2)	Common Stock(3)	3,800	$0	7,602	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.

3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

	Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tenet Healthcare (THC) executive Lisa Y. Foo report on this Form 4?

Lisa Y. Foo reported the vesting and conversion of 3,800 restricted stock units into 3,800 shares of Tenet Healthcare common stock. The transaction reflects an exercise or conversion of a derivative security, not an open-market purchase or sale, under the company’s 2019 Stock Incentive Plan.

How many Tenet Healthcare shares does Lisa Y. Foo hold after this Form 4?

After the reported transactions, Lisa Y. Foo directly holds 53,017 shares of Tenet Healthcare common stock. She also holds 7,602 restricted stock units, which represent additional potential shares that may settle in common stock upon future vesting events according to their original grant terms.

What securities were involved in Lisa Y. Foo’s February 24, 2026 Tenet Healthcare transaction?

The transaction involved 2025 Restricted Stock Units and Tenet Healthcare common stock. On February 24, 2026, 3,800 restricted stock units converted into 3,800 shares of common stock on a one-for-one basis, consistent with time-based awards granted under the company’s 2019 Stock Incentive Plan.

How do Tenet Healthcare restricted stock units convert for Lisa Y. Foo?

Lisa Y. Foo’s restricted stock units convert into common stock on a one-for-one basis upon vesting. These time-based restricted stock units are settled in shares of Tenet Healthcare’s common stock, meaning each vested unit delivers one share without an exercise price being paid at conversion.

What are the vesting terms of Lisa Y. Foo’s 2025 Tenet Healthcare RSU grant?

Her 2025 restricted stock units were granted on February 24, 2025 under the 2019 Stock Incentive Plan. They vest in equal one-third installments on the first, second, and third anniversaries of the grant date. The first one-third installment vested on February 24, 2026, triggering the reported conversion.

Was Lisa Y. Foo’s Tenet Healthcare transaction a stock purchase or sale?

The transaction was classified as an exercise or conversion of a derivative security, not a traditional stock purchase or sale. Restricted stock units vested and were settled in common shares at a zero exercise price, increasing her direct common stock holdings through award settlement rather than market trading.